- $88.94bn
- $115.19bn
- $195.27bn
- 78
- 67
- 79
- 87
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 10.2 | ||
PEG Ratio (f) | 1.19 | ||
EPS Growth (f) | 9.35% | ||
Dividend Yield (f) | 2.1% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.11 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 17.16 | ||
Price to Sales | 0.38 | ||
EV to EBITDA | 10.85 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 7.68% | ||
Return on Equity | 6.92% | ||
Operating Margin | 3.32% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 153,566 | 160,197 | 174,069 | 180,518 | 195,265 | 243,901.27 | 251,924.42 | 32.15% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +3.72 | -34.78 | +58.28 | +5.5 | +61.9 | +0.76 | +9.92 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
Directors
- David Cordani CHM (55)
- Brian Evanko CFO (44)
- Charles Berg CEX (64)
- Eric Palmer CEX (44)
- Jason Sadler CEX (52)
- Michael Triplett CEX (59)
- Noelle Eder EVP (51)
- Kristen Lauria EVP (52)
- Nicole Jones EVP (50)
- John Murabito EVP (62)
- Everett Neville EVP (56)
- Paul Sanford EVP
- Eric Wiseman LED (65)
- William DeLaney IND (65)
- Eric Foss IND (62)
- Elder Granger IND (68)
- Neesha Hathi IND
- George Kurian IND (54)
- Kathleen Mazzarella IND (61)
- Mark Mcclellan IND (57)
- John Partridge IND (71)
- Kimberly Ross IND (56)
- Donna Zarcone IND (63)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- March 6th, 2018
- Public Since
- April 1st, 1982
- No. of Shareholders
- 23,435
- No. of Employees
- 72,500
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 279,839,000
- Address
- 900 Cottage Grove Road, BLOOMFIELD, 06002-2920
- Web
- https://www.thecignagroup.com/
- Phone
- +1 8602266000
- Contact
- Ralph Giacobbe
- Auditors
- PricewaterhouseCoopers LLP
Latest News for CI
Upcoming Events for CI
Q4 2024 Cigna Group Earnings Release
Cigna Group Annual Shareholders Meeting
Q1 2025 Cigna Group Earnings Release
Similar to CI
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
As of Today at 18:57 UTC, shares in Cigna are trading at $317.81. This share price information is delayed by 15 minutes.
Shares in Cigna last closed at $317.81 and the price had moved by +23.21% over the past 365 days. In terms of relative price strength the Cigna share price has underperformed the S&P500 Index by -6.85% over the past year.
The overall consensus recommendation for Cigna is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Cigna dividend yield is 1.71% based on the trailing twelve month period.
Last year, Cigna paid a total dividend of $5.43, and it currently has a trailing dividend yield of 1.71%.Looking ahead, the next dividend pay date is 2024-12-19.
We do not have data on when Cigna is to next pay dividends. The historic dividend yield on Cigna shares is currently 1.71%.
To buy shares in Cigna you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $317.81, shares in Cigna had a market capitalisation of $88.94bn.
Here are the trading details for Cigna:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CI
Based on an overall assessment of its quality, value and momentum Cigna is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cigna is $397.00. That is 24.92% above the last closing price of $317.81.
Analysts covering Cigna currently have a consensus Earnings Per Share (EPS) forecast of $28.51 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cigna. Over the past six months, its share price has underperformed the S&P500 Index by -17.26%.
As of the last closing price of $317.81, shares in Cigna were trading -6.92% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cigna PE ratio based on its reported earnings over the past 12 months is 10.2. The shares last closed at $317.81.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cigna's management team is headed by:
- David Cordani - CHM
- Brian Evanko - CFO
- Charles Berg - CEX
- Eric Palmer - CEX
- Jason Sadler - CEX
- Michael Triplett - CEX
- Noelle Eder - EVP
- Kristen Lauria - EVP
- Nicole Jones - EVP
- John Murabito - EVP
- Everett Neville - EVP
- Paul Sanford - EVP
- Eric Wiseman - LED
- William DeLaney - IND
- Eric Foss - IND
- Elder Granger - IND
- Neesha Hathi - IND
- George Kurian - IND
- Kathleen Mazzarella - IND
- Mark Mcclellan - IND
- John Partridge - IND
- Kimberly Ross - IND
- Donna Zarcone - IND